191 related articles for article (PubMed ID: 26496483)
21. Identification of radiation-induced aberrant hypomethylation in colon cancer.
Bae JH; Kim JG; Heo K; Yang K; Kim TO; Yi JM
BMC Genomics; 2015 Feb; 16(1):56. PubMed ID: 25887185
[TBL] [Abstract][Full Text] [Related]
22. Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas.
Peng D; Guo Y; Chen H; Zhao S; Washington K; Hu T; Shyr Y; El-Rifai W
Sci Rep; 2017 Jan; 7():40729. PubMed ID: 28102292
[TBL] [Abstract][Full Text] [Related]
23. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
[TBL] [Abstract][Full Text] [Related]
24. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
[TBL] [Abstract][Full Text] [Related]
25. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
26. An epigenome-wide methylation study of healthy individuals with or without depressive symptoms.
Shimada M; Otowa T; Miyagawa T; Umekage T; Kawamura Y; Bundo M; Iwamoto K; Ikegame T; Tochigi M; Kasai K; Kaiya H; Tanii H; Okazaki Y; Tokunaga K; Sasaki T
J Hum Genet; 2018 Mar; 63(3):319-326. PubMed ID: 29305581
[TBL] [Abstract][Full Text] [Related]
27. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
28. Detection of fetal epigenetic biomarkers through genome-wide DNA methylation study for non-invasive prenatal diagnosis.
Wang HD; Liu L; Zhao HR; Hou QF; Yan JB; Shi WL; Guo QN; Wang L; Liao SX; Zhu BF
Mol Med Rep; 2017 Jun; 15(6):3989-3998. PubMed ID: 28440505
[TBL] [Abstract][Full Text] [Related]
29. Tools and Strategies for Analysis of Genome-Wide and Gene-Specific DNA Methylation Patterns.
Chatterjee A; Rodger EJ; Morison IM; Eccles MR; Stockwell PA
Methods Mol Biol; 2017; 1537():249-277. PubMed ID: 27924599
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
31. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.
Li Y; Zhang Y; Li S; Lu J; Chen J; Wang Y; Li Y; Xu J; Li X
Sci Rep; 2015 Mar; 5():8790. PubMed ID: 25739977
[TBL] [Abstract][Full Text] [Related]
33. The identification of specific methylation patterns across different cancers.
Zhang C; Zhao H; Li J; Liu H; Wang F; Wei Y; Su J; Zhang D; Liu T; Zhang Y
PLoS One; 2015; 10(3):e0120361. PubMed ID: 25774687
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
35. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
36. Time-course gene profiling and networks in demethylated retinoblastoma cell line.
Malusa F; Taranta M; Zaki N; Cinti C; Capobianco E
Oncotarget; 2015 Sep; 6(27):23688-707. PubMed ID: 26143641
[TBL] [Abstract][Full Text] [Related]
37. Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer.
Kim SJ; Kelly WK; Fu A; Haines K; Hoffman A; Zheng T; Zhu Y
Cancer Lett; 2011 Mar; 302(1):47-53. PubMed ID: 21237555
[TBL] [Abstract][Full Text] [Related]
38. FHIT expression and hypermethylation in esophageal squamous cell carcinoma.
Noguchi T; Takeno S; Kimura Y; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W
Int J Mol Med; 2003 Apr; 11(4):441-7. PubMed ID: 12632095
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
